Wei Cheng

This inventor holds 8 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Enzo Life Sciences, Inc., Enzo Biochem, Inc.. Active years: 2009-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Cheng. Retrieved from https://idiyas.com/inventor/wei-cheng-29v410qr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 21(Granted Patents)

Location History:

Jericho, NY (US) (2009 - 2014)
Seaford, NY (US) (2015)
Valley Stream, NY (US) (2015 - 2016)

Company Filing History:

5 out of 99

Enzo Life Sciences, Inc.

Years Active: 2009-2016

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9492419 - Method for treating crohn'S disease or ulcerative colitis by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain (2016-11-15),

2. 9052324 - Compounds and assays for controlling Wnt activity (2015-06-09),

3. 9046537 - Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain (2015-06-02),

4. 8846952 - Detection or quantification of desirable target molecules, novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes (2014-09-30),

5. 8759526 - Dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes—useful or detection or quantification of desirable target molecules (2014-06-24),

6. 8389729 - Methods for detecting the presence, location or quantity of targets using novel dyes (2013-03-05),

7. 8153802 - Dyes linked to target molecules, oligonucleotides or polynucleotides comprising dye molecules, composite dyes and other compositions useful for detecting or quantifying desirable target molecules (2012-04-10),

8. 7569695 - Dyes for the detection or quantification of desirable target molecules (2009-08-04),

Title: Innovations and Contributions of Inventor Wei Cheng

Introduction

Wei Cheng is a notable inventor based in Jericho, NY (US), recognized for his significant contributions to the field of therapeutic methods. With a total of 8 patents to his name, Cheng has made strides in addressing complex medical conditions through innovative approaches.

Latest Patents

Cheng's latest patents include a method for treating Crohn's disease or ulcerative colitis by administering a compound that binds to the LDL-receptor-related protein (LRP) ligand binding domain. This invention focuses on therapeutic methods, compositions, and uses that influence the behavior of LRP receptors, ultimately aiding in the treatment of inflammatory, immunological, and metabolic conditions. Another significant patent involves compounds and assays for controlling Wnt activity. This invention relates to therapeutic methods for screening compounds based on their ability to influence Wnt activity, utilizing both physical and virtual libraries of compounds.

Career Highlights

Throughout his career, Wei Cheng has worked with prominent companies such as Enzo Life Sciences, Inc. and Enzo Biochem, Inc. His work has been pivotal in advancing therapeutic techniques and understanding complex biological interactions.

Collaborations

Cheng has collaborated with notable colleagues, including Dakai Liu and Elazar S Rabbani, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Wei Cheng's innovative work and patents reflect his dedication to improving therapeutic methods for challenging medical conditions. His contributions continue to influence the landscape of medical research and treatment.

Profile summary based on public USPTO records.